10th Aug 2018 07:42
LONDON (Alliance News) - Intellectual property business IP Group PLC said Friday its portfolio company, Artios Pharma Ltd, has raised GBP65 million.
Artios develops cancer treatments aimed at repairing damaged DNA, and has now completed its oversubscribed Series B financing for GBP65 million, of which IP Group invested GBP5.0 million.
Andera Partners and Life Science partners led the financing, in which both Novartis Venture Fund and Pfizer Ventures were new investors.
Related Shares:
Ip Group